Astrotech (NASDAQ:ASTC) Releases Earnings Results

Astrotech (NASDAQ:ASTC) issued its quarterly earnings results on Wednesday. The aerospace company reported ($2.25) EPS for the quarter, FiscalAI reports. The business had revenue of $0.34 million for the quarter. Astrotech had a negative return on equity of 68.53% and a negative net margin of 1,163.89%.

Astrotech Price Performance

Shares of Astrotech stock traded down $0.01 on Thursday, hitting $2.69. 10,666 shares of the company’s stock traded hands, compared to its average volume of 1,381,670. The company has a fifty day moving average of $3.04 and a two-hundred day moving average of $3.29. Astrotech has a one year low of $1.91 and a one year high of $8.01. The company has a market capitalization of $4.73 million, a price-to-earnings ratio of -0.32 and a beta of -0.25.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded Astrotech from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, April 24th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Astrotech presently has an average rating of “Sell”.

Hedge Funds Weigh In On Astrotech

A number of institutional investors and hedge funds have recently modified their holdings of ASTC. Susquehanna International Group LLP bought a new stake in shares of Astrotech in the 3rd quarter valued at $66,000. DRW Securities LLC raised its holdings in shares of Astrotech by 168.5% during the fourth quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock valued at $109,000 after purchasing an additional 19,747 shares during the period. Finally, J. Safra Sarasin Holding AG acquired a new stake in shares of Astrotech in the 1st quarter valued at about $140,000. 24.35% of the stock is currently owned by institutional investors.

About Astrotech

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.